ERCCI和P53预测Ⅱ期结肠癌FOLFOX方案辅助化疗获益的研究(3)
 |
| 第1页 |
参见附件。
[7] Kim，Min Kyoung. ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer[J].Eur J Cancer，2008，44(1)：54-60.
[8] Smith，Stephanie.ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy[J].J Clin Oncol，2007，25(33)：5172-5179.
[9] Ting，Saskia.ERCC1，MLH1，MSH2，MSH6，and βIII-Tubulin：Resistance proteins associated with response and outcome to platinum-based chemotherapy in m alignant pleural mesothelioma[J] ......
您现在查看是摘要介绍页，详见PDF附件。